252 related articles for article (PubMed ID: 31591470)
1. The necroptosis machinery mediates axonal degeneration in a model of Parkinson disease.
Oñate M; Catenaccio A; Salvadores N; Saquel C; Martinez A; Moreno-Gonzalez I; Gamez N; Soto P; Soto C; Hetz C; Court FA
Cell Death Differ; 2020 Apr; 27(4):1169-1185. PubMed ID: 31591470
[TBL] [Abstract][Full Text] [Related]
2. miR-425 deficiency promotes necroptosis and dopaminergic neurodegeneration in Parkinson's disease.
Hu YB; Zhang YF; Wang H; Ren RJ; Cui HL; Huang WY; Cheng Q; Chen HZ; Wang G
Cell Death Dis; 2019 Aug; 10(8):589. PubMed ID: 31383850
[TBL] [Abstract][Full Text] [Related]
3. Axonal Degeneration Is Mediated by Necroptosis Activation.
Arrázola MS; Saquel C; Catalán RJ; Barrientos SA; Hernandez DE; Martínez NW; Catenaccio A; Court FA
J Neurosci; 2019 May; 39(20):3832-3844. PubMed ID: 30850513
[TBL] [Abstract][Full Text] [Related]
4. Discovery of a Necroptosis Inhibitor Improving Dopaminergic Neuronal Loss after MPTP Exposure in Mice.
Oliveira SR; Dionísio PA; Gaspar MM; Ferreira MBT; Rodrigues CAB; Pereira RG; Estevão MS; Perry MJ; Moreira R; Afonso CAM; Amaral JD; Rodrigues CMP
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069782
[TBL] [Abstract][Full Text] [Related]
5. RIP1/RIP3/MLKL mediates dopaminergic neuron necroptosis in a mouse model of Parkinson disease.
Lin QS; Chen P; Wang WX; Lin CC; Zhou Y; Yu LH; Lin YX; Xu YF; Kang DZ
Lab Invest; 2020 Mar; 100(3):503-511. PubMed ID: 31506635
[TBL] [Abstract][Full Text] [Related]
6. Progressive nigrostriatal terminal dysfunction and degeneration in the engrailed1 heterozygous mouse model of Parkinson's disease.
Nordströma U; Beauvais G; Ghosh A; Pulikkaparambil Sasidharan BC; Lundblad M; Fuchs J; Joshi RL; Lipton JW; Roholt A; Medicetty S; Feinstein TN; Steiner JA; Escobar Galvis ML; Prochiantz A; Brundin P
Neurobiol Dis; 2015 Jan; 73():70-82. PubMed ID: 25281317
[TBL] [Abstract][Full Text] [Related]
7. Ablation of RIP3 protects from dopaminergic neurodegeneration in experimental Parkinson's disease.
Dionísio PA; Oliveira SR; Gaspar MM; Gama MJ; Castro-Caldas M; Amaral JD; Rodrigues CMP
Cell Death Dis; 2019 Nov; 10(11):840. PubMed ID: 31690718
[TBL] [Abstract][Full Text] [Related]
8. Genetic suppression of collapsin response mediator protein 2 phosphorylation improves outcome in methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's model mice.
Togashi K; Hasegawa M; Nagai J; Tonouchi A; Masukawa D; Hensley K; Goshima Y; Ohshima T
Genes Cells; 2019 Jan; 24(1):31-40. PubMed ID: 30375127
[TBL] [Abstract][Full Text] [Related]
9. Dopaminergic neuronal death via necroptosis in Parkinson's disease: A review of the literature.
Regoni M; Valtorta F; Sassone J
Eur J Neurosci; 2024 Mar; 59(6):1079-1098. PubMed ID: 37667848
[TBL] [Abstract][Full Text] [Related]
10. Electroacupuncture Therapy Ameliorates Motor Dysfunction via Brain-Derived Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic Factor in a Mouse Model of Parkinson's Disease.
Pak ME; Ahn SM; Jung DH; Lee HJ; Ha KT; Shin HK; Choi BT
J Gerontol A Biol Sci Med Sci; 2020 Mar; 75(4):712-721. PubMed ID: 31644786
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson's disease.
Tönges L; Frank T; Tatenhorst L; Saal KA; Koch JC; Szego ÉM; Bähr M; Weishaupt JH; Lingor P
Brain; 2012 Nov; 135(Pt 11):3355-70. PubMed ID: 23087045
[TBL] [Abstract][Full Text] [Related]
12. Necroptosis is dispensable for motor neuron degeneration in a mouse model of ALS.
Wang T; Perera ND; Chiam MDF; Cuic B; Wanniarachchillage N; Tomas D; Samson AL; Cawthorne W; Valor EN; Murphy JM; Turner BJ
Cell Death Differ; 2020 May; 27(5):1728-1739. PubMed ID: 31745214
[TBL] [Abstract][Full Text] [Related]
13. Evidence for dopaminergic axonal degeneration as an early pathological process in Parkinson's disease.
O'Keeffe GW; Sullivan AM
Parkinsonism Relat Disord; 2018 Nov; 56():9-15. PubMed ID: 29934196
[TBL] [Abstract][Full Text] [Related]
14. AAV.shRNA-mediated downregulation of ROCK2 attenuates degeneration of dopaminergic neurons in toxin-induced models of Parkinson's disease in vitro and in vivo.
Saal KA; Koch JC; Tatenhorst L; Szegő EM; Ribas VT; Michel U; Bähr M; Tönges L; Lingor P
Neurobiol Dis; 2015 Jan; 73():150-62. PubMed ID: 25283984
[TBL] [Abstract][Full Text] [Related]
15. Repulsive Guidance Molecule a (RGMa) Induces Neuropathological and Behavioral Changes That Closely Resemble Parkinson's Disease.
Korecka JA; Moloney EB; Eggers R; Hobo B; Scheffer S; Ras-Verloop N; Pasterkamp RJ; Swaab DF; Smit AB; van Kesteren RE; Bossers K; Verhaagen J
J Neurosci; 2017 Sep; 37(39):9361-9379. PubMed ID: 28842419
[TBL] [Abstract][Full Text] [Related]
16. Alpha-Synuclein affects neurite morphology, autophagy, vesicle transport and axonal degeneration in CNS neurons.
Koch JC; Bitow F; Haack J; d'Hedouville Z; Zhang JN; Tönges L; Michel U; Oliveira LM; Jovin TM; Liman J; Tatenhorst L; Bähr M; Lingor P
Cell Death Dis; 2015 Jul; 6(7):e1811. PubMed ID: 26158517
[TBL] [Abstract][Full Text] [Related]
17. Extracellular Zn
Tamano H; Nishio R; Morioka H; Takeda A
Mol Neurobiol; 2019 Jan; 56(1):435-443. PubMed ID: 29705946
[TBL] [Abstract][Full Text] [Related]
18. Prolonged Dysfunction of Astrocytes and Activation of Microglia Accelerate Degeneration of Dopaminergic Neurons in the Rat Substantia Nigra and Block Compensation of Early Motor Dysfunction Induced by 6-OHDA.
Kuter K; Olech Ł; Głowacka U
Mol Neurobiol; 2018 Apr; 55(4):3049-3066. PubMed ID: 28466266
[TBL] [Abstract][Full Text] [Related]
19. Axonal degeneration of nigra-striatum dopaminergic neurons induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
Li LH; Qin HZ; Wang JL; Wang J; Wang XL; Gao GD
J Int Med Res; 2009; 37(2):455-63. PubMed ID: 19383240
[TBL] [Abstract][Full Text] [Related]
20. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.
Wegrzynowicz M; Bar-On D; Calo' L; Anichtchik O; Iovino M; Xia J; Ryazanov S; Leonov A; Giese A; Dalley JW; Griesinger C; Ashery U; Spillantini MG
Acta Neuropathol; 2019 Oct; 138(4):575-595. PubMed ID: 31165254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]